NSAIDS/related drugs & steroids Flashcards
NSAIDS administration & elimination
Oral administration
Metabolized by liver & secreted in urine
NSAIDS (MOA)
Completely inhibit COX-1/2 active sites thus inhibiting prostaglandin production resulting in antipyretic, analgesic, and anti inflammatory effects
NSAIDS adverse effects
Anorexia, nausea, dyspepsia, abdominal pain & diarrhea
Gastric ulceration with regular use (inhibits prostaglandins which releases bicarbonate and reduces acid)
Renal failure (some conditions such as cardiac failure, hepatic cirrhosis, chronic renal disease, renal blood flow is dependent on the vasodilator effects of prostaglandins)
Coadministration of PGE1 analog, misoprostol, or proton pump inhibitors (omeprazole) can prevent duodenal & gastric ulcerations
Impairment of platelet function (prevents formation of TXA2 by platelets resulting in impairment of platelet aggregation and increased bleeding)
Hypersensitivity to NSAIDS can be fatal if they are used (less common in children, 10-25% adults with asthma and/or nasal polyps- symptoms are rhinitis, generalized urticaria to laryngeal edema, hypotension and circulatory collapse and death; thought to be due to blockade of COX leading to increased leukotrienes
NSAIDS drug interactions
Glucocorticoids, low dose aspirin (for cardio protection)- increased risk for GI ulceration
Warfarin- increased bleeding risk (inhibit metabolism of warfarin and platelet function)
NSAIDS contraindications
Hypersensitivity to aspirin or other NSAIDS
3 Main NSAIDS
Celecoxib
Naproxen
Ibuprofen
Celecoxib
NSAID
COX-2 selective with less severe GI toxicity than non-selective NSAIDS
Usual dosing has no effect on platelet aggregation
Naproxen
NSAID
Longest half life of 3 main NSAIDS making twice a day dosing possible
Ibuprofen
NSAID
Aspirin MOA
Salicylate
Aka acetylsalicylic acid; converted to active compound salicylic acid in plasma by esterases
Covalently modify COX-1/2 irreversibly inhibiting activity
Duration of action varies depending on tissues COX turnover rate
Exhibits antipyretic, analgesic, and anti inflammatory effects by inhibiting prostaglandin production
Aspirin administration & elimination
Oral & rectal suppository
Metabolized in liver, excreted in urine
Plasma half life of 20 min., 2-3 hrs for salicylate low dose, 30 hrs at toxic level
One of few drugs to exhibit zero order kinetics (disproportionate increase in plasma with increasing dose)
At low doses eliminated by first order processes, at high the liver enzymes become saturated increasing unmetabolized aspirin excretion in urine
Increasing urine pH hastens elimination of salicylic acid due to ion trapping
Aspirin adverse effects
Same as NSAIDS
Bleeding time is especially increased due to irreversible inhibition of COX
Reye’s syndrome in children with viral infections- consists of acute noninflammatory encephalopathy, hepatic dysfunction, and various metabolic derangements
Aspirin drug interactions
Same as NSAIDS
Aspirin contraindications
Children w/ viral infections
NSAID hyper sensitivities
Salicylate poisoning symptoms
Nausea, vomiting, diaphoresis, tinnitus which progresses to diminished auditory acuity with potential deafness as CNS conc. increases
Other CNS effects- vertigo, hyperventilation (due to uncoupling of oxidative phosphorylation increasing CO2) manifested as hyperpnea or tachnypnea, hyperactivity, agitation, delirium, hallucinations, convulsions, lethargy, stupor
Hyperthermia (due to uncoupling of oxidative phosphorylation)- preterminal sign of severe toxicity
Uncoupling also causes acidosis (decreased blood pH from increasing lactic and pyruvic acid levels)